Business & Finance
Cross Country Healthcare reports $162.9 million for third quarter 2006
Published in Pharma Investments, Ventures and Law Weekly, December 10th, 2006
Net income for the third quarter was negatively impacted by a previously disclosed after-tax charge of approximately $5.4 million, or $0.17 per diluted share, related to the settlement of a lawsuit. Excluding this charge, the Company had net income of $5.5 million, or $0.17 per diluted share. A year earlier, the company had revenue of $163.1 million and net income of $5.0 million, or $0.15 per diluted share in the third quarter of 2005. Cash flow from operations for the third quarter of 2006...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Business & Finance
Angiotech Pharmaceuticals reports income of $0.19 per share - Business & Finance
Connetics reports third quarter financial results - Business & Finance
Cutera reports 32% third-quarter revenue increase over same period last year - Business Update
China Medical Technologies and Chinese Academy of Sciences Institute of Acoustics form lab - Business Update
Drager Medical and Masimo announce expanded relationship - Business Update
EDS selected to support anti-fraud program at Centers for Medicare & Medicaid Services - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
